Ataru Igarashi
Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama 236-0027, JapanKyoko Ishida
Ohashi Medical Center, Toho University, Tokyo 153-8515, JapanNobuyuki Shoji
Department of Ophthalmology, Kitasato University Hospital, Kanagawa 252-0375, JapanAlice Chu
Market Access and Medical Marketing, Glaukos Singapore, Singapore 068896, SingaporeHeather Falvey
Global Health Economics, Glaukos Corp, California 92672, USARu Han
Health Economics and Outcomes Research, Creativ-Ceutical, Paris 75008, FranceMaki Ueyama
Health Economics and Outcomes Research, Creativ-Ceutical, Tokyo 108-6028, JapanYoshie Onishi
Health Economics and Outcomes Research, Creativ-Ceutical, Tokyo 108-6028, JapanAtaru Igarashi. Yokohama City University School of Medicine, Unit of Public Health and Preventive Medicine, 3-9 Fukuura, Kanazawa Ward, Yokohama 236-0027, Japan. atarui1@mac.com
Ataru Igarashi, Kyoko Ishida, Nobuyuki Shoji,/et al.iStent inject and cataract surgery for mild-to-moderate primary open angle glaucoma in Japan: a cost-utility analysis. Int J Ophthalmol, 2022,15(6):954-961
Copy